Among over 12,000 patients in 11 high-risk groups, there were no differences in the prevention of pulmonary embolism, proximal deep vein thrombosis (DVT), or bleeding complications between those ...

Consecutive patients with active cancer and proximal deep-vein thrombosis or pulmonary embolism who had completed at least 6 months of anticoagulant therapy were randomly assigned in a 1:1 ratio ...

Pulmonary embolism was a common outcome in many studies ... One study done in 1973 was a study of 129 patients with proximal femoral fractures. [38] It was a single center trial where participants ...